Thursday, October 23, 2014

Top Cheapest Stocks For 2014

The S&P 500 (SNPINDEX: ^GSPC  ) has soared in the past four years, leading many to fear that the index is long overdue for a major correction. In times of trouble, value investors often look to stocks that trade at low valuations compared with their peers to provide a margin of safety from a potential downturn.

Yet judging stocks on a single valuation metric can lead to misleading conclusions that can prove costly. Today, let's take a look at some of the least expensive stocks in the S&P on a price-to-book value basis, with an eye toward understanding why book value might not be the best way to judge whether these stocks are truly cheap.

The cheapest stocks in the S&P
On a book-value basis, financial stocks have had low book values for a long time. Genworth Financial (NYSE: GNW  ) trades at just one-third of book value, while plenty of other insurance companies and banks offer price-to-book ratios of between 0.5 and 0.75. Yet during the financial crisis, investors learned just how inaccurate book values were. Massive writedowns of toxic assets proved necessary to reflect the actual value of those assets, and as a result, price-to-book ratios temporarily soared even as stock prices plunged.

10 Best Airline Stocks To Buy For 2015: Green Technology Solutions Inc (GTSO)

Green Technology Solutions Inc (GTSO), incorporated on February 22, 1991, is in the business of identifying and acquiring rights in early stage, green technologies, with the plan to develop these technologies into marketable products. The Company has identified several technology endeavors.

As of December 31, 2011, the Company has identified the advancement of mining technologies, with an emphasis on rare earth and precious metals mining applications, the development of additional markets for existing paint products that are being marketed in the United States, and smart grid technology. GTSO has also identified additional joint venture in China and South America.

Advisors' Opinion:
  • [By CRWE]

    Today, GTSO has shed (-5.66%) down -0.0018 at $.0300 with�22,150 shares in play thus far (ref. google finance Delayed: 11:34AM EDT July 3, 2013), but don�� let this get you down.

    Previously after forging a new joint venture, Green Technology Solutions, Inc. and Chilerecicla are already hard at work identifying new Latin American companies and locales ideally suited to the partnership�� ambitious expansion plans.

    The partnership has targeted Latin America for expansion because it�� a key emerging market in the booming global e-waste recycling and reuse services industry, which Transparency Market Research predicts accounted for more than $9 billion in 2012. The firm expects the worldwide e-waste market to reach $18 billion in 2017, growing at a compound annual growth rate of 13.2 percent from 2012 to 2017.

  • [By CRWE]

    Today, GTSO has shed (-10.51%) -0.0041 at $.0349 with 1,304,937 shares in play thus far (ref. google finance Delayed: 2:03PM EDT August 13, 2013).

    Green Technology Solutions, Inc. and its partner, Chilerecicla, are preparing to expand recycling operations into Bolivia.

    One of South America�� top recyclers of e-waste, Chilerecicla operates the first e-waste recycling plant in Southern Chile and maintains crucial relationships with overseas smelters, with the right to sell them as many recovered metals and minerals as GTSO and Chilerecicla can provide. With a feasibility study on the region now complete, the joint venture has targeted Bolivia as an ideal territory for growth.

  • [By CRWE]

    Today, GTSO surged (+0.32%) up +0.0001 at $.0309 with 12,300 shares in movement thus far (ref. google finance Delayed: 10:31AM EDT June 20, 2013).

    Green Technology Solutions, Inc. previously reported it has finalized a joint venture agreement with leading Latin American e-waste recycler Chilerecicla.

    Latin America is a key emerging market in the booming the global e-waste recycling and reuse services industry, which Transparency Market Research predicts accounted for more than $9 billion in 2012. The firm expects the worldwide e-waste market to reach $18 billion in 2017, growing at a compound annual growth rate of 13.2 percent from 2012 to 2017.

Top Cheapest Stocks For 2014: Ultra Clean Holdings Inc.(UCTT)

Ultra Clean Holdings, Inc., together with its subsidiaries, engages in the design, development, engineering, manufacture, and sale of critical modules and subsystems primarily to original equipment manufacturers in semiconductor capital equipment, flat panel, medical, energy, and research industries. It offers gas delivery systems that control the flow, pressure, sequencing, and mixing of specialty gases into and out of the reaction chambers of semiconductor manufacturing tools; chemical mechanical planarization modules; chemical delivery modules, which deliver gases and reactive chemicals from a centralized subsystem to the reaction chamber; and top-plate assemblies that form the top portion of the reaction chamber. The company also provides frame assemblies that form the support structure to which other assemblies are attached and include pneumatic harnesses and cables that connect other critical subsystems together; process modules, which are subsystems of semiconductor manufacturing tools that process integrated circuits onto wafers; and other high level assemblies for use in semiconductor manufacturing, research, flat panel, energy, and medical equipment industries. It sells its products through its direct sales force primarily in North America, Asia, and Europe. Ultra Clean Holding, Inc. was founded in 1991 and is headquartered in Hayward, California.

Advisors' Opinion:
  • [By John Kell]

    Ultra Clean Holdings Inc.(UCTT) swung to a fourth-quarter profit as the company recorded a surge in revenue. The company also issued a rosy first-quarter outlook, pushing shares up 17% to $13.94 premarket.

Top Cheapest Stocks For 2014: Select Sector Utilities Select Sector SPDR Fund (XLU)

Select Sector Utilities Select Sector SPDR Fund (the Fund), formerly Utilities Select Sector SPDR Fund, seeks to provide investment results that correspond to the price and yield performance of the Utilities Select Sector of the S&P 500 Index (the Index). The Index includes companies that produce, generate, transmit or distribute electricity or natural gas.

The Fund utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. The Fund�� investment advisor is SSgA Funds Management, Inc.

Advisors' Opinion:
  • [By Mark Salzinger]

    The surging US stock market left staid utilities behind in 2013; while the S&P 500 (SPX) gained more than 32%, SPDR Select Sector Utilities (XLU) gained only about 13%, a decent absolute gain, but a poor relative one.

  • [By Tom Aspray]

    If you are willing to spend the time and do the work, I think you can become your own investment analyst. These more active investors should consider a core position in an S&P-500-tracking ETF and then allocate to other industry-specific ETFs. So far in 2014, the Select Sector SPDR Utilities (XLU) is up 8.8% for the year. Not too far behind is the Select Sector SPDR Health Care (XLV), which is up 7.8%.

Top Cheapest Stocks For 2014: CEL-SCI Corp (CVM)

CEL-SCI Corporation (CEL-SCI), incorporated on March 22, 1983, is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.

Multikine

CEL-SCI's Multikine, is being developed for the treatment of cancer. It is a cancer immunotherapy drugs called Combination Immunotherapy because it combines active and passive immunity in one product. It is the only cancer immunotherapy that both kills cancer cells and activates the general immune system to destroy the cancer. Multikine target the tumor micro-metastases for treatment failure. Multikine is also applicable in many other solid tumors.

New Manufacturing Facility

CEL-SCI's facility manufactures Multikine for CEL-SCI's Phase III clinical trial. CEL-SCI offers the use of the facility as a service to pharmaceutical companies and others, particularly those that need to fill and finish their drugs in a cold environment. Fill and finish is the process of filling injectable drugs in a sterile manner.

LEAPS

CEL-SCI's patented T-cell Modulation Process uses heteroconjugates to direct the body to choose a specific immune response. The heteroconjugate technology, referred to as LEAPS, is intended to stimulate the human immune system to fight bacterial, viral and parasitic infections, as well as autoimmune, allergies, transplantation rejection and cancer. Administered like vaccines, LEAPS combines T-cell binding ligands with small, disease associated and peptide antigens.

Using the LEAPS technology, CEL-SCI has created a peptide treatment for H1N1 (swine flu) hospitalized patients. This LEAPS flu treatment is designed to focus on the conserved, non-changing epitopes of the di! fferent strains of Type A Influenza viruses, including swine, avian or bird, and Spanish Influenza. CEL-SCI's LEAPS flu treatment contains epitopes.

Advisors' Opinion:
  • [By Bryan Murphy]

    It may not have blazed a trail into the young, immunology segment of the biotech industry the way Dendreon Corporation (NASDAQ:DNDN) did back in 2010 with the debut of Provenge. It may not have the same immunology pipeline (and company size) that ImmunoGen, Inc. (NASDAQ:IMGN) boasts. One thing is pretty certain about cancer-immunotherapy developer CEL-SCI Corporation (NYSEMKT:CVM) right now, however - its stock may be poised to dole out a much bigger foreseeable-future reward than DNDN or IMGN are.

Top Cheapest Stocks For 2014: Grifols SA (GRFS)

Grifols SA is a Spain-based company engaged in the healthcare sector. The Company is involved in the research, development, manufacturing and marketing of medical solutions for hospitals, which include plasma-derived therapies, as well as diagnosis and pharmaceutical products. Its activities are structured in four segments: Bioscience, which focuses on the research for obtaining new therapies and solutions aimed at patients who suffer from illnesses stemming from plasma deficits; Diagnostic, which comprises the research, development and marketing of diagnostic products for clinical laboratories, Hospital, which offers ready-to-use pharmaceutical preparations and products for clinical nutrition; and Raw Materials, which includes sales of biological products and services. The Company is a parent of Grupo Grifols. In March 2013, the Company acquired a 60% stake in Progenika Biopharma SA. On January 9, 2014, the Company acquired a diagnostic unit from Novartis International AG. Advisors' Opinion:
  • [By Monica Wolfe]

    Grifols SA (GRFS)

    Paulson�� fourth largest holding is in Grifols SA where he holds on to 19,786,279 shares of the company�� stock. His position in the company represents 4% of his total portfolio and 5.76% of the company�� shares outstanding.

Top Cheapest Stocks For 2014: Maui Land & Pineapple Company Inc. (MLP)

Maui Land & Pineapple Company, Inc., together with its subsidiaries, engages in the development, sale, and leasing of real estate properties. It owns approximately 23,300 acres of land on Maui. The company also offers water and waste transmission services. In addition, it manages certain resort amenities at the Kapalua Resort. The company was founded in 1909 and is based in Lahaina, Hawaii.

Advisors' Opinion:
  • [By Dividends4Life]

    Sunoco Logistics Partners (SXL) is a master limited partnership (MLP) that was formed by Sunoco Inc. to acquire, own and operate a group of refined product and crude oil pipelines and terminal facilities.
    Yield: 3.6% | Years of Dividend Growth: 11

  • [By Matthew Skelly]

    The technology of fracturing (and the horizontal style of drilling), is changing America's needs on the energy front. At the epicenter of this infrastructure build-out is Atlas Pipeline Partners (NYSE:APL), a midstream gathering and processing company that trades as a Master Limited Partnership, (MLP). Atlas Pipeline is essentially a middle man between the drillers and long-haul transportation pipelines. It gathers mixed volumes of natural gas and natural gas liquids (NGLs) such as ethane, propane, and butanes, etc. from the thousands of wells drilled by its drilling customers, back through pipelines to its processing plants, which will separate the gas from the NGLs. Both are then sold to long-haul transportation pipelines, which take the two products downstream to the next part of the energy supply chain.

No comments:

Post a Comment